Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Milk in rice could curdle

26.04.2002


Biotech human breast milk growing but not bottled.



Genetically modified (GM) rice carrying a protein from human breast milk could be used to enhance infant formula, researchers hope. But at present, the protein would not gain approval for use in the United States.

Nutritionists agree that breast milk is best for a baby; infant formula is not as nourishing as the real thing. So for mothers unable to breast-feed, the biotech industry is engineering crops or animals to make human breast milk proteins to ’humanize’ formula.


Yuriko Adkins of the University of California, Davis and her colleagues, have modified rice plants to carry a human gene for a milk enzyme called lactoferrin. Babies need this to use iron efficiently and fight infection.

Rats fed the rice-raised ’recombinant’ enzyme together with a second enzyme, lysozyme, were better able to kill gastrointestinal bacteria, she told the Experimental Biology 2002 meeting this week in New Orleans. Sterilization inactivates the lactoferrin in current cow-based infant formula; the GM form is stable.

But the US Food and Drug Administration (FDA) will not approve the recombinant protein, warned Steve Taylor of the University of Nebraska, who has been involved in worldwide GM food committees. "I’m about to throw a bit of cold water on this debate," he said.

To test if GM products could cause an allergic reaction, the FDA compares a GM protein with known human allergens - including lactoferrin from cows.

The FDA’s regulations are designed to cover biotech plants that carry drugs or pesticides. They will have to be rethought before rice-grown lactoferrin, and other human proteins made by genetically modified organisms, can be approved for production, says Taylor.

Researchers may be able to bypass the regulatory process if they can prove that the recombinant protein acts identically in the gut to the human one. The two might then be treated as the same, hopes Todd Stoltz of Ventria Bioscience, the company planning commercial production of the human proteins in rice.

Murky milk

In future, recombinant proteins might be used to customize milk formulas, for example to enhance premature babies’ nutrient absorption or to help newborns fight HIV. HIV-positive mothers are advised against breast-feeding by the World Health Organization.

Human breast-milk proteins are already experimentally produced in organisms ranging from fungi to cows. "These proteins are out there by the tonne," says Bo Lonnerdal, who studies them at the University of California, Davis. Yet it is unclear exactly what some of them do in the body, or what tests must be done to demonstrate that they are safe and effective.

For example, there are no animal models that adequately mimic human allergy. And it is unclear whether an animal’s response to a human protein is comparable to that of a person.

Babies fed breast milk develop fewer infections than those on formula and have different gut bacteria. But there’s no guarantee that consumers will accept humanized biotech milk; they may be particularly concerned about feeding GM food to their baby. "It’s a very emotive issue," says Lonnerdal.

HELEN PEARSON | © Nature News Service

More articles from Life Sciences:

nachricht Multi-institutional collaboration uncovers how molecular machines assemble
02.12.2016 | Salk Institute

nachricht Fertilized egg cells trigger and monitor loss of sperm’s epigenetic memory
02.12.2016 | IMBA - Institut für Molekulare Biotechnologie der Österreichischen Akademie der Wissenschaften GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>